Patents by Inventor Carl Simon SHELLEY

Carl Simon SHELLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of novel diagnostics and therapeutics by modulating RhoH
    Patent number: 10746739
    Abstract: The disclosure relates to identifying novel therapeutic targets and/or diagnostic and/or prognostic markers by correcting abnormal RhoH expression in a hematopoietic cell.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: August 18, 2020
    Assignee: Leukemia Therapeutics, LLC
    Inventor: Carl Simon Shelley
  • IDENTIFICATION OF NOVEL DIAGNOSTICS AND THERAPEUTICS BY MODULATING RHOH
    Publication number: 20170074883
    Abstract: The disclosure relates to identifying novel therapeutic targets and/or diagnostic and/or prognostic markers by correcting abnormal RhoH expression in a hematopoietic cell.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Applicant: Leukemia Therapeutics, LLC
    Inventor: Carl Simon Shelley
  • METHOD FOR TREATING CHRONIC LYMPHOID LEUKEMIA
    Publication number: 20080293661
    Abstract: Embodiments of the invention relates to the treatment of chronic lymphoid leukemia. The invention provides treatment, diagnostic, and drug discovery strategies for chronic lymphoid leukemia. Reconstitution of RhoH expression in vitro inhibits neoplastic proliferation and the process of trans-endothelial migration that underlies much of the pathology of CCL. RhoH reconstitution also limits malignant progression in vivo. Therefore, RhoH reconstitution represents a new therapeutic strategy in the fight against chronic lymphoid leukemia.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 27, 2008
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Carl Simon SHELLEY, Sylvie GALIEGUE-ZOUITINA